Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia

Schizophrenia Research

Volumn 102, Issue 1-3, 2008, Pages 210-219

  Pedrosa, Erika ^a   Stefanescu, Radu ^a   Margolis, Benjamin ^a   Petruolo, Oriana ^a   Lo, Yungtai ^a   Nolan, Karen ^b   Novak, Tomas ^c   Stopkova, Pavla ^c   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Bipolar disorder; Cadherin schizophrenia; Chromatin; Protocadherin

Indexed keywords

CADHERIN; PROTEIN PROTOCADHERIN ALPHA; PROTEIN PROTOCADHERIN BETA; PROTEIN PROTOCADHERIN GAMMA;

ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ALTERNATIVE SPLICING; ANIMALS; BIPOLAR DISORDER; CADHERINS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; CONTROL GROUPS; ENHANCER ELEMENTS (GENETICS); FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; MALE; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; VARIATION (GENETICS);

EID: 46249106282     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.04.013     Document Type: Article

References (76)

1. Bernstein B.E., Kamal M., Lindblad-Toh K., Bekiranov S., Bailey D.K., Huebert D.J., McMahon S., Karlsson E.K., Kulbokas III E.J., Gingeras T.R., Schreiber S.L., and Lander E.S. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120 2 (2005) 169-181
2. Blair I.P., Chetcuti A.F., Badenhop R.F., Scimone A., Moses M.J., Adams L.J., Craddock N., Green E., Kirov G., Owen M.J., Kwok J.B., Donald J.A., Mitchell P.B., and Schofield P.R. Positional cloning, association analysis and expression studies provide convergent evidence that the cadherin gene FAT contains a bipolar disorder susceptibility allele. Mol. Psychiatry 11 4 (2006) 372-383
3. Bonn S., Seeburg P.H., and Schwarz M.K. Combinatorial expression of α- and γ-protocadherins alters their presenilin-dependent processing. Mol. Cell. Biol. 27 11 (2007) 4121-4132
4. Bray N.J., Kirov G., Owen R.J., Jacobsen N.J., Georgieva L., Williams H.J., Norton N., Spurlock G., Jones S., Zammit S., O'Donovan M.C., and Owen M.J. Screening the human protocadherin 8 (PCDH8) gene in schizophrenia. Genes Brain Behav. 1 3 (2002) 187-191
5. Dean B., Keriakous D., Scarr E., and Thomas E.A. Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust. N. Z. J. Psych. 41 4 (2007) 308-320
6. DeLisi L.E., Mesen A., Rodriguez C., Bertheau A., LaPrade B., Llach M., Riondet S., Razi K., Relja M., Byerley W., and Sherrington R. Genome-wide scan for linkage to schizophrenia in a Spanish-origin cohort from Costa Rica. Am. J. Med. Genet. 114 5 (2002) 497-508
7. Devlin B., Bacanu S.A., Roeder K., Reimherr F., Wender P., Galke B., Novasad D., Chu A., Tcuenco K., Tiobek S., Otto C., and Byerley W. Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol. Psychiatry 7 7 (2002) 689-694
8. Durand C.M., Kappeler C., Betancur C., Delorme R., Quach H., Goubran-Botros H., Melke J., Nygren G., Chabane N., Bellivier F., Szoke A., Schurhoff F., Rastam M., Anckarsater H., and Eichler E.E. Widening the spectrum of human genetic variation. Nat. Genet. 38 1 (2006) 9-11
9. Endicott J., and Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 7 (1978) 837-844
10. Esumi S., Kakazu N., Taguchi Y., Hirayama T., Sasaki A., Hirabayashi T., Koide T., Kitsukawa T., Hamada S., and Yagi T. Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons. Nat. Genet. 37 2 (2005) 171-176
11. Fanous A.H., Chen X., Wang X., Amdur R.L., O'Neill F.A., Walsh D., and Kendler K.S. Association between the 5q31.1 gene neurogenin1 and schizophrenia. Am. J. Med. Genet. B (Neuropsychiatr. Genet.) 144 2 (2007) 207-214
12. Frank M., and Kemler R. Protocadherins. Curr. Opin. Cell. Biol. 14 5 (2002) 557-562
13. Giouzeli M., Williams N.A., Lonie L.J., DeLisi L.E., and Crow T.J. ProtocadherinX/Y, a candidate gene-pair for schizophrenia and schizoaffective disorder: a DHPLC investigation of genomic sequence. Am. J. Med. Genet. B (Neuropsychiatr. Genet.) 129 1 (2004) 1-9
14. Gottesman I.I., and Bertelsen A. Confirming unexpressed genotypes for schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch. Gen. Psychiatry 46 10 (1989) 867-872
15. Gould T.D., Dow E.R., O'Donnell K.C., Chen G., and Manji H.K. Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway. CNS. Neurol. Disord. Drug Targets 6 3 (2007) 193-204
16. Gurling H.M., Kalsi G., Brynjolfson J., Sigmundsson T., Sherrington R., Mankoo B.S., Read T., Murphy P., Blaveri E., McQuillin A., Petursson H., and Curtis D. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 68 3 (2001) 661-673
17. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39 2 (2007) 311-318
18. Herzberg I., Jasinska A., Garcia J., Jawaheer D., Service S., Kremeyer B., et al. Convergent linkage evidence from two Latin-American population isolates supports the presence of a susceptibility locus for bipolar disorder in 5q31-34. Hum. Mol. Genet. 15 21 (2006) 3146-3153
19. Hirayama T., and Yagi T. The role and expression of the protocadherin-alpha clusters in the CNS. Curr. Opin. Neurobiol. 16 3 (2006) 336-342
20. Hong K.S., McInnes L.A., Service S.K., Song T., Lucas J., Silva S., Fournier E., Leon P., Molina J., Reus V.I., Sandkuijl L.A., and Freimer N.B. Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am. J. Med. Genet. B (Neuropsychiatr. Genet.) 125 1 (2004) 83-86
21. Hope B.T., Kelz M.B., Duman R.S., and Nestler E.J. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci. 14 (1994) 4318-4328
22. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ujike H., and Ozaki N. Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patients. Biol. Psychiatry 58 6 (2005) 440-445
23. Jamra R.A., Becker T., Klopp N., Dahdouh F., Schulze T.G., Gross M., Deschner M., Schmal C., Illig T., Rietschel M., Propping P., Cichon S., Nothen M.M., and Schumacher J. No evidence for an association between variants at the gamma-amino-n-butyric acid type A receptor beta2 locus and schizophrenia. Psychiatr. Genet. 17 1 (2007) 43-45
24. Jarskog L.F., Miyamoto S., and Lieberman J.A. Schizophrenia: new pathological insights and therapies. Annu. Rev. Med. 58 (2007) 49-61
25. Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., and Sawa A. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell. Biol. 7 12 (2005) 1067-1078
26. Kaneko R., Kato H., Kawamura Y., Esumi S., Hirayama T., Hirabayashi T., and Yagi T. Allelic gene regulation of Pcdh-alpha and Pcdh-gamma clusters involving both monoallelic and biallelic expression in single Purkinje cells. J. Biol. Chem. 281 41 (2006) 30551-30560
27. Kato T., Iwamoto K., Kakiuchi C., Kuratomi G., and Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol. Psychiatry 10 7 (2005) 622-630
28. Kawaguchi M., Toyama T., Kaneko R., Hirayama T., Kawamura Y., and Yagi T. Relationship between DNA methylation states and transcription of individual isoforms encoded by the protocadherin-alpha gene cluster. J. Biol. Chem. (2008) Jan 18 [Electronic publication ahead of print]
29. Kendler K.S., Myers J.M., O'Neill F.A., Martin R., Murphy B., MacLean C.J., Walsh D., and Straub R.E. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am. J. Psychiatry 157 3 (2000) 402-408
30. Kerner B., Brugman D.L., and Freimer N.B. Evidence of linkage to psychosis on chromosome 5q33-34 in pedigrees ascertained for bipolar disorder. Am. J. Med. Genet. B (Neuropsychiatr. Genet.) 144 1 (2007) 74-78
31. Kirov G., Georgieva L., Williams N., Nikolov I., Norton N., Toncheva D., O'Donovan M., and Owen M.J. Variation in the protocadherin gamma A gene cluster. Genomics 82 4 (2003) 433-440
32. Kohmura N., Senzaki K., Hamada S., Kai N., Yasuda R., Watanabe M., Ishii H., Yasuda M., Mishina M., and Yagi T. Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. Neuron 20 6 (1998) 1137-1151
33. Kwiatkowski A.V., Weis W.I., and Nelson W.J. Catenins: playing both sides of the synapse. Curr. Opin. Cell. Biol. (2007) [Electronic publication ahead of print]
34. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta_analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am. J. Hum. Genet. 73 1 (2003) 34-48
35. Liu J., Shi Y., Tang W., Guo T., Li D., Yang Y., Zhao X., Wang H., Li X., Feng G., Gu N., Zhu S., Liu H., Guo Y., Shi J., Sang H., Yan L., and He L. Positive association of the human GABA-A-receptor beta 2 subunit gene haplotype with schizophrenia in the Chinese Han population. Biochem. Biophys. Res. Commun. 334 3 (2005) 817-823
36. Lo W.S., Harano M., Gawlik M., Yu Z., Chen J., Pun F.W., Tong K.L., Zhao C., Ng S.K., Tsang S.Y., Uchimura N., Stober G., and Xue H. GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol. Psychiatry 61 5 (2007) 653-660
37. Mackie S., Millar J.K., and Porteous D.J. Role of DISC1 in neural development and schizophrenia. Curr. Opin. Neurobiol. (2007) [Electronic publication ahead of print] PMID:17258902
38. Maier W., Zobel A., and Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 19 2 (2006) 165-170
39. Meijerink J., Mandigers C., van de Locht L., Tonnissen E., Goodsaid F., and Raemaekers J. A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real_time PCR. J. Mol. Diagnostics 3 2 (2001) 55-61
40. Menon B., Johnson J.N., Ross R.S., Singh M., and Singh K. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: role of beta1 integrins. J. Mol. Cell. Cardiol. 42 3 (2007) 653-661
41. Morishita H., Umitsu M., Murata Y., Shibata N., Udaka K., Higuchi Y., Akutsu H., Yamaguchi T., Yagi T., and Ikegami T. Structure of the cadherin related neuronal receptor/protocadherin alpha first extracellular cadherin domain reveals diversity across cadherin families. J. Biol. Chem. 281 44 (2006) 33650-33663
42. Mullen R.D., Colvin S.C., Hunter C.S., Savage J.J., Walvoord E.C., Bhangoo A.P., Ten S., Weigel J., Pfäffle R.W., and Rhodes S.J. Roles of the LHX3 and LHX4 LIM-homeodomain factors in pituitary development. Mol. Cell. Endocrinol. 265-266 (2007) 190-195
43. Noonan J.P., Li J., Nguyen L., Caoile C., Dickson M., Grimwood J., Schmutz J., Feldman M.W., and Myers R.M. Extensive linkage disequilibrium, a common 16.7_kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster. Am. J. Hum. Genet. 72 3 (2003) 621-635
44. Oberley M.J., Tsao J., Yau P., and Farnham P.J. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays. Methods Enzymol. 376 (2004) 315-334
45. Onstad S., Skre I., Torgersen S., and Kringlen E. Twin concordance for DSMIIIR schizophrenia. Acta Psychiatr. Scand. 83 5 (1991) 395-401
46. Paunio T., Ekelund J., Varilo T., Parker A., Hovatta I., Turunen J.A., Rinard K., Foti A., Terwilliger J.D., Juvonen H., Suvisaari J., Arajarvi R., Suokas J., Partonen T., Lonnqvist J., Meyer J., and Peltonen L. Genome_wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum. Mol. Genet. 10 26 (2001) 3037-3048
47. Petronis A. Epigenetics and bipolar disorder: new opportunities and challenges. Am. J. Med. Genet. C (Semin. Med. Genet.) 123 1 (2003) 65-75
48. Petryshen T.L., Middleton F.A., Tahl A.R., Rockwell G.N., Purcell S., and Aldinger K.A. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol. Psychiatry 10 12 (2005) 1074-1088
49. Pimm J., McQuillin A., Thirumalai S., Lawrence J., Quested D., Bass N., Lamb G., Moorey H., Datta S.R., Kalsi G., Badacsonyi A., Kelly K., Morgan J., Punukollu B., Curtis D., and Gurling H. The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am. J. Hum. Genet. 76 5 (2005) 902-907
50. Ponchel F., Toomes C., Bransfield K., Leong F.T., Douglas S.H., Field S.L., Bell S.M., Combaret V., Puisieux A., Mighell A.J., Robinson P.A., Inglehearn C.F., Isaacs J.D., and Markham A.F. Real_time PCR based on SYBR_Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol. 3 (2003) 18
51. Procopio M. Does God play dice with schizophrenia? A probabilistic model for the understanding of causation in mental illness. Med. Hypotheses 64 4 (2005) 872-877
52. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., et al. Global variation in copy number in the human genome. Nature 444 7118 (2006) 444-454
53. Ribich S., Tasic B., and Maniatis T. Identification of long-range regulatory elements in the protocadherin-{alpha} gene cluster. Proc. Natl. Acad. Sci. 103 52 (2006) 19719-19724
54. Roberts R.C. Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr. Bull. 33 1 (2007) 11-15
55. Roh T.Y., Wei G., Farrell C.M., and Zhao K. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res. 17 1 (2007) 74-81
56. Roh T.Y., Cuddapah S., and Zhao K. Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping. Genes Dev. 19 5 (2005) 542-552
57. Ross N.L., Mavrogiannis L.A., Sargent C.A., Knight S.J., Wadekar R., DeLisi L.E., and Crow T.J. Quantitation of X-Y homologous genes in patients with schizophrenia by multiplex polymerase chain reaction. Psychiatr. Genet. 13 2 (2003) 115-119
58. Sanders A.R., Rusu I., Duan J., Vander Molen J.E., Hou C., Schwab S.G., Wildenauer D.B., Martinez M., and Gejman P.V. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol. Psychiatry 10 4 (2005) 353-365
59. Sano K., Tanihara H., Heimark R.L., Obata S., Davidson M., St John T., Taketani S., and Suzuki S. Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J. 12 6 (1993) 2249-2256
60. Sawamura N., and Sawa A. Disrupted-in-schizophrenia 1 (DISC1): a key susceptibility factor for major mental illnesses. Ann. N. Y. Acad. Sci. 1086 (2006) 126-133
61. Schwab S.G., Eckstein G.N., Hallmayer J., Lerer B., Albus M., Borrmann M., Lichtermann D., Ertl M.A., Maier W., and Wildenauer D.B. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol. Psychiatry 2 2 (1997) 156-160
62. Scott J., McNeill Y., Cavanagh J., Cannon M., and Murray R. Exposure to obstetric complications and subsequent development of bipolar disorder: systematic review. Br. J. Psychiatry 189 (2006) 3-11
63. Sklar P., Pato M.T., Kirby A., Petryshen T.L., Medeiros H., Carvalho C., Macedo A., Dourado A., Coelho I., Valente J., Soares M.J., Ferreira C.P., Lei M., Verner A., Hudson T.J., Morley C.P., Kennedy J.L., Azevedo M.H., Lander E., Daly M.J., and Pato C.N. Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol. Psychiatry 9 2 (2004) 213-218
64. Spitzer R.L., Endicott J., and Robins E. Research diagnostic criteria: rationale and reliability. Arch. Gen. Psychiatry 35 (1978) 773-782
65. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., and Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry 7 6 (2002) 542-559
66. Straub R.E., MacLean C.J., O'Neill F.A., Walsh D., and Kendler K.S. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol. Psychiatry 2 2 (1997) 148-155
67. Tang R.Q., Zhao X.Z., Shi Y.Y., Tang W., Gu N.F., Feng G.Y., Xing Y.L., Zhu S.M., Sang H., Liang P.J., and He L. Family-based association study of Epsin 4 and Schizophrenia. Mol. Psychiatry 11 4 (2006) 395-399
68. Tasic B., Nabholz C.E., Baldwin K.K., Kim Y., Rueckert E.H., Ribich S.A., Cramer P., Wu Q., Axel R., and Maniatis T. Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol. Cell 10 1 (2002) 21-33
69. Tsuang M. Schizophrenia: genes and environment. Biol. Psychiatry 47 3 (2000) 210-220
70. Wang X., Su H., and Bradley A. Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model. Genes Dev. 16 15 (2002) 1890-1905
71. Wang K., Li M., Hadley D., Liu R., Glessner J., Grant S.F., Hakonarson H., Bucan M., and Penn C.N.V. An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. (2007) [Electronic publication ahead of print]
72. Weksberg R., Hughes S., Moldovan L., Bassett A.S., Chow E.W., and Squire J.A. A method for accurate detection of genomic microdeletions using real_time quantitative PCR. BMC Genomics 6 (2005) 180
73. Wu Q., and Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97 6 (1999) 779-790
74. Xu X., Bieda M., Jin V.X., Rabinovich A., Oberley M.J., Green R., and Farnham P.J. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res. 17 11 (2007) 1550-1561
75. Yagi T., and Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 14 10 (2000) 1169-1180
76. Zou C., Huang W., Ying G., and Wu Q. Sequence analysis and expression mapping of the rat clustered protocadherin gene repertoires. Neuroscience 144 2 (2007) 579-603